IN8bioINAB -0.45%24 FCF Yield % is -111.53 as of Jun. 28, 2026. GuruFocus rates INAB with a GF Score™ of 24/100. Among 1,416 Biotechnology companies, IN8bio ranks worse than 91.45% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, IN8bio's Trailing 12-Month Free Cash Flow is $-14.55 Mil, and Market Cap is $13.04 Mil. Therefore, IN8bio's FCF Yield % for today is -111.53%.
The historical rank and industry rank for IN8bio's FCF Yield % or its related term are showing as below:
INAB'
s FCF Yield % Range Over the Past 10 Years
Min: -111.53 Med: 0 Max: 0
Current: -111.53
INAB's FCF Yield % is ranked worse than 91.45% of 1416
companies
in the Biotechnology industry
Industry Median: -9.62
vs INAB: -111.53
IN8bio's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
IN8bio FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
IN8bio FCF Yield % Related Terms
IN8bio FCF Yield % Historical Data
* Premium members only.
The historical data trend for IN8bio's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, IN8bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IN8bio FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IN8bio's FCF Yield % distribution charts can be found below:
* The bar in red indicates where IN8bio's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IN8bio (INAB) has a FCF Yield % of -111.53 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on IN8bio and its competitors. According to the industry distribution chart, IN8bio ranks #1295 out of 1416 companies in the Biotechnology industry, placing it in the top 91.5%.
Is IN8bio's FCF Yield % too high?
IN8bio's current FCF Yield % is -111.53. Based on the distribution chart, IN8bio ranks #1295 out of 1416 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, IN8bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does IN8bio's FCF Yield % compare to ZIVO and LPCN?
According to the Biotechnology industry distribution chart, IN8bio ranks #1295 out of 1416 companies for FCF Yield %. This places IN8bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on IN8bio and its competitors. IN8bio's current FCF Yield % is -111.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IN8bio stock overvalued right now?
IN8bio (INAB) has a current FCF Yield % of -111.53. The current FCF Yield % is -111.53. IN8bio's overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For IN8bio (INAB), the current FCF Yield % is -111.53 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
24GF Score
Get the complete analysis for INAB
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INAB has been successfully added to your 
